190 related articles for article (PubMed ID: 36831605)
1. CD169
Briem O; Källberg E; Kimbung S; Veerla S; Stenström J; Hatschek T; Hagerling C; Hedenfalk I; Leandersson K
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831605
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer associated CD169
Gunnarsdottir FB; Briem O; Lindgren AY; Källberg E; Andersen C; Grenthe R; Rosenqvist C; Millrud CR; Wallgren M; Viklund H; Bexell D; Johansson ME; Hedenfalk I; Hagerling C; Leandersson K
Front Immunol; 2023; 14():1180209. PubMed ID: 37404831
[TBL] [Abstract][Full Text] [Related]
3. Co-localization of CD169
Björk Gunnarsdottir F; Auoja N; Bendahl PO; Rydén L; Fernö M; Leandersson K
Oncoimmunology; 2020 Nov; 9(1):1848067. PubMed ID: 33299660
[TBL] [Abstract][Full Text] [Related]
4. CD169
Nagata M; Ishizaka K; Asano T
Res Rep Urol; 2023; 15():1-7. PubMed ID: 36660299
[TBL] [Abstract][Full Text] [Related]
5. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
[TBL] [Abstract][Full Text] [Related]
6. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
7. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S; Kawahara K; Fujiwara Y; Ohnishi K; Pan C; Yano H; Hirosue A; Nagata M; Hirayama M; Sakata J; Nakashima H; Arita H; Yamana K; Gohara S; Nagao Y; Maeshiro M; Iwamoto A; Hirayama M; Yoshida R; Komohara Y; Nakayama H
Cancer Immunol Immunother; 2022 Sep; 71(9):2127-2139. PubMed ID: 35044489
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
Li M; Li A; Zhou S; Xu Y; Xiao Y; Bi R; Yang W
BMC Cancer; 2018 Jan; 18(1):4. PubMed ID: 29291717
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CD169-positive macrophages in various tumors: a meta-analysis.
Kong W; Wei M; Liu R; Zhang J; Wang X
Bioengineered; 2021 Dec; 12(1):8505-8514. PubMed ID: 34607536
[TBL] [Abstract][Full Text] [Related]
13. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.
Kumamoto K; Tasaki T; Ohnishi K; Shibata M; Shimajiri S; Harada M; Komohara Y; Nakayama T
Front Oncol; 2021; 11():636751. PubMed ID: 33816277
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
16. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
17. CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients.
Zhang J; Xu J; Zhang RX; Zhang Y; Ou QJ; Li JQ; Jiang ZZ; Wu XJ; Fang YJ; Zheng L
Oncoimmunology; 2016 Jul; 5(7):e1177690. PubMed ID: 27622027
[TBL] [Abstract][Full Text] [Related]
18. Loss of CD169
Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
[TBL] [Abstract][Full Text] [Related]
19. High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.
Takeya H; Shiota T; Yagi T; Ohnishi K; Baba Y; Miyasato Y; Kiyozumi Y; Yoshida N; Takeya M; Baba H; Komohara Y
Pathol Int; 2018 Dec; 68(12):685-693. PubMed ID: 30516869
[TBL] [Abstract][Full Text] [Related]
20. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
